跳至主要内容
临床试验/ACTRN12608000610336
ACTRN12608000610336招募中未知

Dexamphetamine modulation of brainwave activity and prepulse inhibition in healthy participants

Mathew Martin-Iverson0 个研究点目标入组 30 人开始时间: 2008年12月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnancy or currently breastfeeding
  • 2. hearing disorders
  • 3. neurological disorders or known seizure risk
  • 4. history of loss of consciousness for over 15 min
  • 5. current diagnosis or treatment for a mental illness
  • 6. past or current treatment for substance use disorder
  • 7. significant risk of psychosis
  • 8. presence or history of a kinetic disorder
  • 9. presence or history of hypertension
  • 10. presence or history of hepatic insufficiency
  • 11. presence renal insufficiency
  • 12. presence or history of cardiovascular disorder
  • 13. significant risk of suicide
  • 14. known hypersensitivity to amphetamines
  • 15. receiving any systemic prescription medication (excluding contraceptives)

研究者

发起方
Mathew Martin-Iverson

相似试验